Scilex Holding Company (SCLX) financial statements and ratios from SEC XBRL: revenue $30.25M (TTM), net margin -1236.4%, revenue growth -46.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $30.25M |
| Net Margin | -1236.4% |
| Revenue Growth (YoY) | -46.5% |
| EPS Growth (YoY) | 6414.3% |
| FCF Growth (YoY) | -81.0% |
| Price / Sales | 1.36 |
| FCF Yield | -17.6% |
| Altman Z-Score | -8.00 (distress) |
| Piotroski F-Score | 4/9 |
| Sector P/E (Healthcare) | 21.7 |
SCLX overview · SCLX earnings · SCLX KPIs · SCLX investor relations · SCLX ownership · SCLX peers · SCLX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.